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Abstract: The increasing technological applications of palladium nanoparticles (Pd-NPs) and their
consequent enhancing release into the community and occupational environments, have raised
public health concerns regarding possible adverse effects for exposed subjects, and particularly
for workers chronically and highly exposed to these materials, whose toxico-kinetic and dynamic
behavior remains to be fully understood. Therefore, this review aimed to critically analyze literature
data to achieve a more comprehensive knowledge on the toxicological profile of Pd-NPs. Results
from available studies demonstrated the potential for these chemicals to affect the ecosystem
function, to exert cytotoxic and pro-inflammatory effects in vitro as well as to induce early alterations
in different target organs in in vivo models. However, our revision pointed out the need for
future studies aimed to clarify the role of the NP physico-chemical properties in determining their
toxicological behavior, as well as the importance to carry out investigations focused on environmental
and biological monitoring to verify and validate experimental biomarkers of exposure and early effect
in real exposure contexts. Overall, this may be helpful to support the definition of suitable strategies
for the assessment, communication and management of Pd-NP occupational risks to protect the
health and safety of workers.
Keywords: palladium nanoparticles; ecotoxicity; cytotoxic effects; in vivo toxicity; biomarkers of
exposure; biomarkers of effect; risk assessment; risk management
1. Introduction
Modern science has experienced one of its major breakthroughs with nanotechnology in the last
decades. This enabled nano-dimensional materials (in the 1–100 nm size domain) to be produced
and applied in a number of technological and consumer fields due to their peculiar physico-chemical
properties [1].
Metallic based nanomaterials have attracted great scientific attention in the nanotechnology field.
Particularly, given that noble metals are characterized by remarkable catalytic, electronic, magnetic,
optical, and mechanical properties per se [2–4], the study of the characteristics and possible uses
of nano-sized noble metal materials has emerged as hugely important and valuable for the benefits
potentially offered in a number of different applications.
In this regard, palladium (Pd) is a rare and precious metal that belongs to the Platinum group
elements. It is largely employed as an active catalyst material in automotive catalytic converters,
but finds also application in the electronic, engineering, biomedical, and jewelry sectors [5–8].
Palladium-NPs offer the opportunity for being even more effective catalyst materials due to their high
surface area to volume ratio and high surface energy [9].
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Therefore, the emerging applications of these NPs, as detailed in the next paragraph, and the
consequent enhanced likelihood of human exposure due to the release of such materials in living and
occupational environments, raise public health and scientific concerns over possible environmental
and human health implications [10]. From an occupational health perspective, this seems an even more
urgent issue to assess, since workers may become highly and chronically exposed to these still not-fully
explored nanomaterials. In this context, it is important to achieve a deeper and more comprehensive
understanding of the inherent toxicity of Pd-NPs, with the purpose of a safe handling and use of
these innovative materials. Therefore, the aim of this review was to revise potential applications of
Pd-NPs and critically assess available knowledge concerning possible toxicological effects induced
by Pd-NPs on in vitro, ex vivo and in vivo models in order to extrapolate critical issues important for
understanding potential risks for workers.
2. Possible Pd-NP Applications
Palladium-NPs are characterized by invaluable catalytic, mechanical and optical properties which
may offer the opportunity for their employment in a number of industrial applications. In this regard,
Pd-NPs have been extensively investigated for a wide range of chemical applications [11]. Their catalyst
potential, related to the ability to dissociate molecular hydrogen into the atomic state, has been applied
in organic carbon–carbon coupling formation, i.e., the Suzuki–Miyaura and the Heck cross-coupling
reactions [12–15], hydrogenations of unsaturated olefins [13], and alcohol oxidations [16]. Overall, this
potential has been successfully employed to control the hazardous exhaust emissions from automotive
engines, to process environmental pollutants, as well as to produce intermediates of pharmaceuticals
and fine chemicals [17,18]. Additionally, Pd-NPs exhibited excellent degradation of methylene blue,
methyl orange and nitrophenol dyes, and therefore, they can be employed to treat the effluents polluted
with such compounds [11].
Apart from the organic catalysis, Pd nanomaterials have been widely used in electro-catalysis.
The property of Pd to adsorb hydrogen has led Pd-NPs to be employed in hydrogen storage [19,20],
and electrochemical reactions in fuel cells [21]. Carbon microspheres-supported Pd-NPs possess
excellent electro-catalytic properties and may be of great potential in direct ethanol fuel cells [22].
palladium nanostructures have gained interest in the last decade also in a number of other applications
including the composition of electrical equipment [23,24] or as sensors for the detection of various
analytes [20], i.e., Pd-NPs doped with chitosan–graphene have been employed as biosensors for glucose
estimation [25]. In medicine, Pd nanosheets and Pd-NPs have been investigated for photothermal
therapy and as anti-tumor/anti-microbial agents, although they have still not been practically exploited
in this therapeutic fields [17].
3. In Vitro Studies
A number of studies reported the ability of Pd-NPs to exert eco-toxicological adverse effects
on seed germination [26], pollen [27] and plant growth [28]. Significant cytotoxic effects were also
detected in several human cellular models, including respiratory cells [29,30], peripheral blood [31],
and cervical [32–34], liver [35], ovarian [4] as well as skin melanoma cancer cells [36], although no
unique modes of action could be defined. Additionally, a pro-inflammatory action of Pd-NPs was
demonstrated by increased levels of cytokines as key mediators of such effect [29,37,38] (Table 1).
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Table 1. Studies investigating the effects of Pd-NPs on in vitro models.
Palladium-NP Characterization Investigated Models Experimental Design Endpoints Results References
Plants
Size: 1–12 nm Barley(Hordeum vulgare) plants
Seeds were cultivated in a
floating hydroponic system
containing a nutrient solution
(0–50 µmol Pd/L) for 1 week
Leaf length
Leaf length significantly decreased according to the increased
exposure concentrations (105–115 mm after 50 µmol Pd vs.
120–125 mm of unexposed plants).
Battke et al. [28]
Pd-NPs entrapped in an aluminum
hydroxide matrix Lettuce seeds
Seeds were planted
immediately (day 0) or 15 day
after adding NPs to the soil
(0.013 and 0.066% w/w)
Seed germination and growth
Shoot/root ratio: no significant influence.
on the difference in the ratio when the seeds were planted on
day 0. palladium-NPs at low concentration significantly
increased the ratio (2.5 cm) compared to controls (1.41 cm) in
soils incubated with NPs for 15 d.
Shah and Bazelerova, [26]
Size: 5–10 nm
Kiwifruit pollen from
plants of the male
genotype of Actinidia
deliciosa var. deliciosa
Pollen was exposed to 0–7
mg/L NPs for up to 90 min Pollen performance and lethality
Tube emergence and growth: significant inhibition began at 0.1
mg/L, complete growth cessation at 0.4 mg/L.
Lethality: as concentration increased, viability exponentially
decreased (LC50 at 90 min: 1.0 ± 0.3 mg/L).
Speranza et al. [27]
Halloysite supported Pd-NPs.
Tube diameter: 50 nm;
Inner lumen diameter: 15 nm;
Surface area: 65 m2/g
High and low vigor
R. sativus
Radish seeds were exposed to
10 mL of nanomaterials at
concentrations ranging 0–1500
mg/L for up to 72 h
Germination and seedling development
Exposure to Halloysite -PdNPs had no significant influence on
germination, seedling development, xylem differentiation, or
mitotic index in both lots.
Bellani et al. [39]
Animal cells
Chemical composition:
Pd/magnetite;
Size: 20–30 nm;
Purity: ≥98%
Surface area: 46.4 ± 0.2 m2/g
RTgill-W1 Cells were exposed to 5–25mg/L NPs for 1 h and 3 days Cell viability
Metabolic activity and membrane integrity showed a
significant decrease after 1 h exposure due to cellular stress.
Cell viability was full restored after 3 days.
Hildebrand et al. [40]
Size: 10 ± 6 nm Rat-1 Cells were exposed to 1 and2 µg/mL NPs for 2–120 h
Cell viability; Oxidative stress reaction;
cell cycle distribution; DNA damage
Cell viability was significantly reduced by both concentrations
at 120 h.
Cell cycle distribution: time-dependent increase in G0/G1
phase (from 45% in controls to 70% following 2 µg/mL for 120
h). Decrease of cell percentage in the S phase (from 30% in
controls to 15% following 2 µg/mL for 120 h).
DNA damage: a significant effect was evident only following
treatment with 2 µg/mL for 120 h.
ROS production: significant increase compared to controls only
after 2 µg/mL NPs for 2 and 4 h.
Iavicoli et al. [30]
Human cells
Size: 5–10 nm PBMCs from 8 non-atopichealthy donors
Cells were overnight incubated
with NPs (10−5, 10−6 M), with
or without 10 µg/mL
LPS stimulation
Cell viability; Cytokine release
Cell viability: not affected by all conditions of exposure.
Cytokine release (no LPS): 10−5 M Pd-NPs significantly
inhibited TNF-α and IL-17.
Cytokine release (with LPS): 10−5 M Pd-NPs significantly
inhibited TNF-α and IL-17 and increased INF-γ. Pd-NPs (10−6
M) significantly inhibited IL-17.
Boscolo et al. [37]
Size: 5–10 nm
PBMCs from 12
non-atopic and
8 atopic donors
Cells were overnight incubated
with NPs (10−5 M), with or
without 10 µg/mL
LPS stimulation
Cell viability; Cytokine release
Cell viability: not affected by all conditions of exposure.
Cytokine release (no LPS): no significant effects on cytokine
release. Cytokine release (with LPS): NPs significantly reduced
TNF-α and increased INF-γ levels in cells from non-atopic
subjects. NPs reduced TNF-α in cells from atopic subjects.
Reale et al. [38]
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Table 1. Cont.
Palladium-NP Characterization Investigated Models Experimental Design Endpoints Results References
Chemical composition:
Pd/magnetite;
Size: 20–30 nm;
Purity: ≥98%
Surface area: 46.4 ± 0.2 m2/g
Caco-2, Hacat
Cells were exposed to
5–25 mg/L NPs for 1 h and
3 days
Cell viability;
Oxidative stress reaction
Hacat cells: viability was reduced to app. 91 ± 3% for all tested
concentrations. After 3 days cell viability recovered up to 94%
except with highest dose. Caco-2 cells showed similar tendency.
No significant ROS production was demonstrated in
comparison to controls.
Hildebrand et al. [40]
Size: 10.4 ± 2.7 nm;
Shape: spherical PBECs, A549
Cells were exposed to
0–25 µg/mL NPs for 24 h
Cell viability;
Oxidative stress reaction;
inflammatory response
Cell viability: no alterations up to 10 µg/mL, decreased by
higher concentrations.
PBEC apoptosis: dose-dependently induced.
ROS: no significant induction.
IL-8: significantly increased at 0.01 and 10 µg/mL, and
decreased at 0.1 µg/mL in A549 cells; significantly decreased at
1 µg/mL for PBECs compared to controls.
PGE2: significantly decreased at 0.1 and 10 µg/mL in A549
cells; significantly decreased at all the concentrations tested for
PBECs compared to controls.
Wilkinson et al. [29]
Zerovalent NPs;
Size: 2–8 nm
PBMCs from
healthy donors
Cells were exposed to
0–80 µg/mL NPs for 4–72 h
following PHA stimulation
(48 h)
Cell viability;
Oxidative stress reaction;
Cell cycle distribution
No alterations in cell viability (4 h); Significant reduction at 80
(24 h), 20 (48 h) and 10 µg/mL (72 h).
A moderate (n.s.) intracellular ROS increase was induced by
NP exposure.
Cell cycle distribution: PHA-stimulated PBMCs (G0/G1:
43.1 ± 1.9%; S: 48.8 ± 2.3%; G2/M: 8.1 ± 1.2%); 10 µg/mL NPs
(G0/G1: 59.8 ± 1.8%; S: 35.4 ± 1.5%; G2/M: 4.8 ± 1.2%).
Petrarca et al. [31]
Size: 3.8 ± 0.4–26.6 ± 2.2 nm;
Agglomerate size: 50–150 nm THP-1
Cells were exposed to
0–450 µg/mL NPs Oxidative stress reaction
A linear dependence of ROS production was evident up to
100 µg/mL. Above this level ROS levels were leveled off. Neubauer et al. [41]
Pd-NPs obtained through leaf
extracts of Evolvulus alsinoides.
Shape: spherical;
Size: 27 ± 2 nm
A2780 Cells were exposed to0–10 µg/mL NPs for 24 h Cell viability; Oxidative stress reaction
Cell viability: doses greater than 6 µg/mL NPs induced a
significant reduction compared to controls.
ROS production: dose-dependent, significant increase in
treated cells compared to controls.
Apoptosis: induced by NP treatment compared to controls.
Gurunathan et al. [4]
Pd nanosheets; positively charged
CA-Pd nanosheets; Negatively
charged 3-MPA-Pd-nanosheets
HepG2
Cells were incubated with
nanosheets at 0–100 ppm
for 24 h
Cell viability
Pd nano-sheets: 93.2 ± 6.8% at 50 ppm; 74.7 ± 8.5% at 100 ppm.
CA-Pd nano-sheets: 42.4 ± 11.9% at 50 ppm; 17.93 ± 3.74% at
100 ppm.
MPA-Pd nano-sheets: 83.7 ± 8.54% at 50 ppm; 68.4 ± 3.9% at
100 ppm.
Pan et al. [35]
Pd-NPs synthesized through leaf
extract of Eclipta prostrate.
Size: 18–64 nm (average size
27 ± 1.3 nm);
Aggregate sizes: 63 ± 1.4 nm
HepG2 Cells were incubated withnanosheets at 0–500 µg/mL Cell viability
Cytotoxicity was 8.5, 24, 48, 65, and 76.5% of cells treated with
1, 10, 100, 250, 500 µg/mL. Rajakumar et al. [33]
Pd-nanocubes
Size: ~10 nm HeLa
Cells were exposed to
425 µg/mL Pd-nanocubes
for 24 h
Cell viability
Percent of non-viable cells (necrotic or late apoptotic): 6.6%
with serum, 14.7% without serum.
Percent of apoptotic cells: ~7% with serum, 23% without serum
(DNA fragmentation test).
Dahal et al. [34]
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Table 1. Cont.
Palladium-NP Characterization Investigated Models Experimental Design Endpoints Results References
Size: 10 ± 6 nm A549 Cells were exposed to 1 and2 µg/mL NPs for 4–120 h
Cell viability; Oxidative stress reaction;
cell cycle distribution; DNA damage
Cell viability was significantly reduced by 2 µg/mL NPs at 96
and 120 h.
Cell cycle distribution: time-dependent increase in G0/G1
phase (40% in controls to 80% following 2 µg/mL for 120 h).
Decrease of cell percentage in the S phase (from 30% in controls
to 15% following 2 µg/mL for 120 h).
DNA damage: a significant effect was evident after 2 µg/mL at
all time points.
ROS production: significant increase compared to controls only
for 2 µg/mL NPs for 4 h.
Iavicoli et al. [30]
Shape: spherical;
Size: 6–10 nm
Hydrodynamic diameter: 138 ± 3
and 151 ± 6 nm in ethanol and
KSFM medium, respectively
Bronchial mucosa 3D
model: PBECs and MRC-5
Bronchial cells [stimulated or
not with IL-13 (1 ng/mL)] were
exposed to aerosolized NPs at
250, 400 and 650 ng/cm2
for 24 h
Cell viability;
Release of inflammatory mediators
No alterations in cell viability.
IL-8 release: significantly increased in the basal medium
following the medium dose exposure in the normal model and
the highest concentration in IL-13 stimulated model, compared
to controls.
Ji et al. [42]
Pd-NPs and bimetallic Pt-Pd-NPs
obtained through the extract of
Dioscorea bulbifera.
Pd-NP shape: spherical and blunt
ended cubes;
Pt-Pd-NP shape: irregular;
Size: 10–25 nm
HeLa Cells were exposed to10 µg/mL NPs for 48 h Cell viability
Reduced by 33.15% by Pd-NPs and by 74.25% by Pt-Pd-NPs.
Immunofluorescence analysis indicated apoptosis of the treated
cells (higher in geoups treated with bimetallic NPs than
with Pd-NPs).
Anti-scavenging activity: greater for bimetallic NPs than
individual Pd-NPs.
Ghosh et al. [32]
Mean size (±SD): 14.70 ± 2.30 nm A375
Cells were exposed to
0–40 µg/mL NPs for 24 and
48 h
Cell viability; Oxidative stress reaction;
Cell cycle
Cell viability: dose- and time-dependent significant reduction
(62.3% and 75.94% decrease at 24 and 48 h, compared to
controls).
ROS production: significantly increased by all concentrations
of Pd-NPs. A significant reduction of GSH, 15.76% and 49.73%,
compared to controls was induced by 40 µg/mL at 24 and 48 h,
respectively.
Cell cycle (24 h): cells in sub-G1 stage increased from 0.78%
(untreated group) to 5.59% and 15.28%, at 20 µg/mL and
40 µg/mL concentrations, respectively.
Alarifi et al. [36]
Size: 1–10 nm;
Hydrodynamic diameter in water:
446.9 ± 14.1 nm
Human eosinophilic cell
line AML14.3D10 and
freshly isolated
eosinophils
Cells were incubated with
0–150 µg/mL NPs for up to
24 h
Cell viability; Oxidative stress reaction
Cell viability: no significant alterations in necrotic and
apoptotic cells.
ROS production: no significant alterations.
Cytoskeleton rearrangement: actin was diffusely stained in the
cytoplasm after NP treatment.
Adhesion to endothelial cells: increased by a factor of 1.6 ± 0.2
(3D10 cell line treated with NPs); 1.7 ± 0.4 (freshly eosinophils
treated with NPs) which are close to 1.8 ± 0.2 of
positive controls.
Chhay et al. [43]
3D model, three dimensional model; A2780, human ovarian cancer cells; A375, human skin malignant melanoma cells; A549, transformed alveolar basal human epithelial cells;
CA, cysteamine; Caco-2 cells, human colon adenocarcinoma cells; HaCat, human keratinocyte cells; HeLa, human epithelial cervical cancer cells; HepG2, human liver cancer cell line G2;
LC50, lethal concentration 50; LPS, lypoplysaccharide; MPA, mercaptopropionic acid; n.s., not significant; MRC-5, human fetal lung fibroblast cells; NPs, nanoparticles; Pd, palladium;
PBECs, primary bronchial epithelial cells; PGE2, prostaglandin E2; PHA, phytohemagglutinin-L; PBMCs, peripheral blood mononuclear cells; Rat-1, rat embryo fibroblasts; ROS, reactive
oxygen species; SD, standard deviation; THP-1, human monocyte leukaemia cells.
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3.1. Plant Models
The emerging application of Pd-NPs in many fields inevitably led these chemicals to contaminate
environmental matrices, potentially resulting in bioaccumulation in living organisms. This raised
interest in assessing the effects of such metal-NPs on plant models. In this regard, Battke et al. [28]
provided the first report regarding the plant uptake of Pd-NPs and their phyto-toxic effects. As a sign
of abiotic stress, leaf length of barley plants decreased or became extremely variable, and leaves
developed as rigid and slightly convoluted in response to Pd-NP treatment.
Palladium-NPs were also reported to significantly affect the growth of lettuce seeds, as measured
by shoot to root ratios, when these were planted in soil samples previously incubated with NPs
for 15 days [26]. Conversely, Pd-NPs supported on halloysite nanotubes showed no influence on
radish germination and development of high and low vigor seeds of Raphanus sativus, mitotic index
and chromosomal figures, therefore supporting the biological safety of such nanomaterials [39].
Speranza et al. [27] assessed the effects of Pd-NPs on the performance of kiwifruit pollen cultures,
as an experimental model largely employed to assess the chemical impact on plant cell metabolism.
Palladium-NPs were able to induce morphological alterations of pollen grains, damage to cell
membranes, and depletion of endogenous calcium, therefore resulting in impaired pollen tube
emergence and growth. When NP induced effects were compared to those exerted by PdCl2 on
the same endpoints, higher cyto-toxicity was reported for the nano-sized form, maybe in relation to
a greater metal adsorption derived from NP exposure.
3.2. Animal Cells
Cell viability tests with RTgill-W1 (Oncorhynchus mykiss) fish cell lines showed no obvious acute
toxicity for Pd/magnetite NPs. Metabolic activity and membrane integrity, as cell viability parameters,
showed a slight decreasing trend after 1 h of particle exposure. However, this was attributed to
a cellular stress response induced by NP addition, more than to a specific cytotoxic effect of NPs.
After three days of exposure, cell viability was fully recovered. The third endpoint under study,
lysosomal integrity, did not show any alteration at both periods investigated [40].
Conversely, in the normal diploid Rat-1 fibroblast cell line acutely and sub-acutely treated
with Pd-NPs, a significant dose and time-dependent cell growth inhibition was observed [30].
A cell cycle arrest with accumulation of cells in G0/G1 phases and a significant DNA damage was
evident, although only a slight increase in the intracellular reactive oxygen species (ROS) levels could
be detected.
3.3. Human Cells
3.3.1. Cytotoxic Effects
The exposure to Pd-NPs was reported to induce different toxic effects on various cellular models.
The assessment of cell viability in human colon adenocarcinoma Caco-2 cells and HaCaT keratinocytes,
treated with Pd-NPs, revealed only minor effects, maybe related to the cellular stress caused by the
NP application [40]. On the other hand, Wilkinson et al. [29] showed that the exposure of primary
bronchial epithelial cells (PBECs), and lung carcinoma epithelial cells (A549) used to simulate the upper
and lower respiratory tract, respectively, to Pd-NPs resulted in a concentration-dependent cytotoxicity.
Of note, PBECs were markedly more affected by Pd-NPs than A549 cells. In line with these findings,
apoptosis was induced in a dose-dependent manner by Pd-NPs in PBECs, but not in A549 cells [29].
Nanoparticle chemical composition appeared also relevant to determine cellular viability effects,
since individual Pd-NPs resulted in less cytotoxicity compared to bimetallic Pt-Pd-NPs on human
epithelial cervical cancer HeLa cells [32]. Such enhanced effect could be attributed to a synergistic action
of both components. Also, the type of NP surface coating was reported as a possible influencing factor
for the Pd-NP toxicological profile. Positively charged cysteamine functionalized Pd nanosheets, in fact,
showed a much higher cytotoxicity on human liver HepG2 cancer cells, compared to negatively charged
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3-mercaptopropionic acid functionalized NPs [35]. This was supposed to be related to the stronger
contact that two dimensional, cysteamine functionalized nanosheets may have with cell surface
compared to the mercaptopropionic-acid nanosheets, which aggregated in three dimensional particles,
therefore changing their contact level with the cellular membrane. However, a dose-dependent
cytotoxic effect on HepG2 cells was also reported by Rajakumar et al. [33] with Pd-NPs synthesized
using the aqueous leaf extracts of Eclipsa prostrata. Increasing concentrations were able to induce
cytopathic effects leading to cell damage and necrosis.
When Pd-NP acute and sub-acute cytotoxic effects were investigated on peripheral blood
mononuclear cells (PBMCs) leaving quiescence through a phytohemagglutinin-L stimulation, a time-
and dose-dependent reduction in cell viability could also be detected [31]. Interestingly, non-cytotoxic
Pd-NP doses caused a significant increase of cells within the G0/G1-phase, as demonstrated by
an increased percentage of mitogen activated PBMCs with a diploid DNA content, and a significant
reduction of cells in GS- and G2/M-phases. In line with these results [31], a time and dose-dependent
inhibition of cell growth has been recently demonstrated by Iavicoli et al. [30] in exponentially growing
cultures of A549 cells treated with Pd-NPs for sub-acute periods of time (48–120 h). However, such cell
viability inhibition was less evident compared to that determined in the same study on Rat-1 fibroblasts,
suggesting a species-specific susceptibility to the NP toxicity. Moreover, Pd-NP-induced inhibition
of cell growth was not associated with the induction of apoptosis. As reported by Petrarca et al. [31],
Pd-NPs induced a progressive cell cycle arrest with accumulation of cells in the G0/G1 phase of the
cell cycle, which could suggest a potential toxic effect of Pd-NPs on DNA. According to this statement,
the authors found that Pd-NPs were able to induce a significant increase in DNA breaks already after
4 h of exposure and such damages become even more evident after longer periods of treatment even if
only a slight increase in the intracellular ROS levels could be detected. Alarifi et al. [36] demonstrated
that Pd-NPs not only inhibited human skin malignant melanoma A375 cell proliferation in a dose- and
time-dependent manner, but also induced apoptosis, DNA damage and a cell cycle arrest. Inhibition
of cell growth was specifically related with a reduction of the percentage of cells in the G0/G1 phase
and an accumulation of those in the S and G2/M phases of the cell cycle.
A recent study investigated the possible effects that Pd-NPs exerted on human eosinophil cells
known to have a key role in lung diseases and allergies [43]. In contrast to previous findings,
Pd-NPs did not induce necrotic or apoptotic cellular viability alterations in both human 3D10
eosinophils and primary eosinophil cells in vitro. However, these NPs were able to induce actin
cytoskeleton rearrangement in exposed cells, therefore determining their increased adhesion to
endothelial cells. This was confirmed by the pre-treatment of cells with cytochalasin D, a potent
inhibitor of actin polymerization, which in turn determined levels of adhesion comparable to those
found in untreated controls.
Concerning possible modes of action, oxidative stress is considered as one of the most important
mechanisms for cytotoxic effects of NPs [44]. However, regarding Pd-NPs, an oxidative stress induction
was detected only in A375 human skin malignant melanoma cells [36] and in A2780 human ovarian
cancer cells [4] based on ROS production following an acute or sub-acute treatment, which could be
responsible for the induction of DNA damage and apoptotic-mediated cell death. Gurunathan et al. [4]
also hypothesized that excessive production of ROS could trigger an autophagic phenomenon
in ovarian cancer cells, eventually leading to cytotoxicity. Interestingly, the surface-specific ROS
production of Pd-NPs was reported as being significantly related to the primary particle size,
with a maximum around 12 nm, for both acellular and human leukaemia cellular environments [41].
On the other side, no significant ROS production was observed for Pd-NPs in Caco-2 and Hacat [40],
A549 cells [29,30], PBECs [29], PBMCs [31], and human eosinophils [43].
Therefore, other possible molecular mechanisms should be elucidated for their role in Pd-NP
cytotoxicity. Dahal et al. [34] confirming these results, demonstrated that Pd-nanocubes induced
apoptosis in transformed human epithelial HeLa cells only in serum-free medium. The effect of serum
on compromising the efficacy of Pd-nanocubes in inducing apoptosis can be related to the healing
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properties of proteins, antibodies and antigens present in serum on cytotoxic effects, as well as on
the possibility that these components may form different bio-molecular coronas around nanocubes
changing their biological reactivity. Apoptosis was the primary route of Pd-nanocube-induced cell
death, although it was associated with a hyperpolarization of mitochondria, contrary to common
depolarization initiated by ROS. This may suggest that the mechanism of Pd-nanocube toxicity was
different from cytotoxic effects mediated by oxidative stress reactions.
Regarding the role of solubility in NP-induced effects, Petrarca et al. [31] suggested that Pd
ions, per se or released from NPs could be the inducers of Pd toxicity as assessed comparing effects
induced by Pd(IV) ions and Pd-NPs on PBMCs. Pd ions resulted more toxic, compared to Pd-NPs,
causing almost complete loss of cell viability earlier, and at a lower dose, and a significant ROS
increase. Following Pd (IV) ion exposure, more marked subcellular alterations, i.e., the presence
of numerous auto-phagosomal vacuoles containing damaged mitochondria, and/or undigested
cytoplasmic material, and a significant amplification of cell cycle alterations described for Pd-NPs,
could be demonstrated. This may suggest that Pd ions released from Pd-NPs may have a role in their
toxicological behavior. Metal ions may accumulate in mitochondria damaging their function which
may in turn arrest the cell cycle and cause cell death. However, deeper research is necessary to verify
and confirm such possible mechanism of action.
3.3.2. Immunological and Inflammatory Responses
The immune potential of Pd-NPs was evaluated in a couple of studies through the analysis of
cytokine release and expression in PBMCs of non-atopic [37] and Pd-sensitized women [38]. In the first
study [37], a significant reduction in IL-17 and TNF-α concentrations was induced by NP exposure,
with or without lipopolysaccharide (LPS) stimulation, while the INF-γ release was significantly
enhanced by the highest concentration of NPs in LPS stimulated cells. These results were partially
comparable to those obtained with a Pd salt in the same conditions of exposure, with the exception of
the Pd-NP stimulatory action on the INF-γ release. Overall, this may suggest that Pd-NPs may exert an
important immune modulatory effect in vitro which was also confirmed when such cytokine changes
were investigated in PBMCs obtained from Pd-sensitized non-atopic volunteers [38]. The addition of
10−5 M Pd-NPs did not significantly modify the release of cytokines in LPS un-stimulated cultures,
but induced a significant inhibition of TNF-α release in LPS stimulated PBMCs. These findings
suggested a possible immuno-modulatory effect of Pd-NPs on cytokine release. However, deeper
investigation is necessary to define underlying modes of action in PBMCs from Pd-sensitized or
not-sensitized subjects and possible long-term health implications of such alterations.
Interleukin-8 secretion was also investigated by Wilkinson et al. [29] as a possible biomarker of the
inflammogenic potential of Pd-NPs on PBECs and A459 cells. Additionally, the levels of prostaglandin
E2 (PGE2), potentially involved in a number of biological functions, including vasodilatation and both
anti- and pro-inflammatory action, were also evaluated. A non-linear trend could be detected for the
secretion of IL-8 in response to Pd-NP treatment by A549 lung epithelial cells. A dose-dependent
decrease was evident in the lower concentration range (0.01–1 µg/mL), while a significant increase
compared to controls was achieved at the highest concentration (10 µg/mL). On the other hand,
a dose-dependent decrease could be detected for the PGE2 secretion in both cell types. Notably,
these effects are seen at a non-cytotoxic concentration of Pd-NPs, indicating that these biomarkers
serve as sensitive indicators of the biological effects of Pd-NPs. Recently, a significant, dose-dependent
increase in IL-8 secretion was also reported in a three-dimensional cellular model obtained co-culturing
PBECs and human fetal lung fibroblasts MRC-5 at an air liquid interface, able to mimic an in vivo
healthy and chronic bronchitis-like mucosa acutely exposed to Pd-NPs [42]. This demonstrated that
Pd-NPs could induce an inflammatory response in both mucosal models, although IL-8 concentrations
were significantly higher in the inflamed model compared to the normal one.
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4. Ex Vivo Studies
Skin contact with Pd can result in sensitization and allergic contact dermatitis [45–47]. The Pd-NP
higher surface area to mass ratio may be responsible for greater biological activities compared to
the bulk form of the metal, as well as an easier release of reactive metal ions [48,49], with a greater
potential for skin permeation. To verify this latter aspect, Larese et al. [50] investigated the penetration
of 0.60 mg/cm2 of 10.7 ± 2.8 nm sized Pd-NPs applied on intact and needle-damaged human skin
pieces obtained as a surgical waste from four different donors in an in vitro diffusion cell system.
Human skin absorption of Pd-NPs occurred in both intact and damaged skin, although lesions
increased the metal absorption significantly. The Pd content in intact skin decreased significantly from
the epidermis to the dermis. Inside the skin, these NPs can be a long-term source of metal that could
be involved in the sensitization process or can be available for systemic diffusion.
5. In Vivo Studies
Several biological models, from bacterial strains [51] to mammalian organisms were reported
to be affected by Pd-NP treatment. The immune [52,53], renal [54] and endocrine systems [55]
were demonstrated as critical targets for the toxic action of Pd-NPs (Table 2). The elemental Pd
content in urine, and changes in cytokine serum levels, urinary protein content and hormonal serum
concentrations, emerged as possible biomarkers of Pd-NP exposure and early effect, although further
studies are necessary to confirm these preliminary results and validate their possible employment in
real exposure settings.
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Table 2. Studies investigating the effects of Pd-NPs on in vivo models.
Palladium-NP Characterization Investigated Models Experimental Designs Endpoints Results References
Bacterial models
Pd-NPs entrapped in an aluminum
hydroxide matrix Microcosm soil
NPs were added to the soil at a final
concentration of 0.013% or 0.066% (w/w) Bacterial growth
No significant effects on the number of colony forming units or
on the total soil community metabolic fingerprint. Shah and Belozerova, [27]
Bimetallic Pd-iron NPs Sphingomonas sp. PH-07 Bacterial strain was exposed to 0–0.5 g/L Bacterial growth
No differences compared to controls were evident up to 0.1
g/L, whereas bacterial growth was significantly inhibited with
greater NP concentrations.
Murugesan et al. [56]
Size: 2.0 ± 0.1; 2.5 ± 0.2; 3.1 ± 0.2 nm.
Gram negative E. coli,
Gram positive S. aureus
bacterial strains
Bacteria were exposed to 2.5 × 10−4,
10−5, 10−6, 10−7, 10−8, and 10−9 M for
each size of NPs for 24 h
Bacterial growth
A significant decrease in the amount of colonies/mL over the
24 h exposure time, at the 10−4–10−6 M concentrations was
evident for both microorganisms.
Adams et al. [51]
Pt-Pd polyaniline nanocomposites
Gram positive
(Streptococcus sp. and
Staphylococcus sp.) and
Gram-negative bacteria
(E. coli and Klebsiella sp.)
Bacteria were incubated with
0–150 µg/mL pristine anyline, Pt-Pd
bimetal NPs and Pt-Pd polyaniline
nanocomposites for 24 h
Bacterial growth
The maximum zone of inhibition (mm in diameter) was
observed for polyaniline/Pt-Pd nanocomposite against
Staphylococcus sp. (28 ± 0.70 mm) followed by Klebsiella sp.
(25 ± 0.85 mm), E. coli (22 ± 0.36 mm) and Streptococcus sp.
(21 ± 0.30 mm).
MIC: 25 and 75 µg/mL for anyline and Pt-Pd nanocomposites.
Pt-Pd colloids did not show the zone of inhibition against
investigated pathogens.
Boomi et al. [57]
Pd-NPs obtained throuh methanolic
extraction from M. oleifera peel.
Shape: spherical;
Size: 27 ± 2 nm
Gram negative E. coli,
Gram positive S. aureus
bacterial strains
- Bacterial growth Good antibacterial activity was reported for both Grampositive and Gram negative bacterial strains. Surendra et al. [58]
Pd-NPs obtained through
bio-precipitation in bacterial cultures
Marine Gram negative
bacterium V. fischeri;
PCB-dechlorinating
marine microbial
community cultures from
a sediment collected in
the Venice lagoon, Italy
V. fischeri were exposed to 0–9 µg/mL for
5–30 min.
Marine cultures were exposed to 5 and
50 mg/kgdw for upt to 18 weeks
Bacterial growth of V. fischeri;
Respiratory metabolisms and
structure of the marine
microbial community
Acute toxicity: no significant effects.
Respiratory metabolisms: Pd-NPs did not impact the
dechlorination activities; while dose-dependently inhibited the
sulfate reduction and methanogenesis.
Pd-NPs increased the richness of the microbial community.
Nuzzo et al. [59]
Pd-NPs obtained through leaf extract of
Garciniapedunculata;
Shape: spherical and non-spherical;
Size: ~2 ± 4 nm;
Hydrodynamic diameter: 322 nm
MDR clinical isolate
Cronobacter sakazakii strain
AMD04
Bacterial cultures (1 mL) were incubated
with 0–0.65 mM NPs up to 24 h Bacterial and biofilm growth
Bactericidal activity: a 31.67 ± 1.53 mm diameter zone of
inhibition was evident around the Pd-NP well.
MIC: 0.06 mM; MBC: 0.12 mM.
Biofilm activity: maximum
inhibition at 0.26 ± 0.02 mM. Comparable biomass formation
decrease at 0.39 and 0.52 mM.
Hazarika et al. [60]
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Table 2. Cont.
Palladium-NP Characterization Investigated Models Experimental Designs Endpoints Results References
Animal models
Size: 10 ± 6 nm
Female Wistar rats
(n. 4 per group)
Animals were exposed to a single
intravenous injection of Pd-NPs at 0–12
µg/kg dose. Serum cytokine
concentrations were assessed at the 14th
day post-exposure
Effects on the immune system
The highest dose of Pd-NPs (12 µg/kg) induced a significant
increase of IL-1α, IL-4, IL-6, IL-10, IL-12, GM-CSF and INF-γ
compared to controls.
The 0.12 µg/kg dose induced a significant increase of IL-2, IL-4,
IL-10 serum concentrations.
Iavicoli et al. [52]
Female Wistar rats
(n. 5 per group)
Animals were exposed to repeated (on
day 1, 30 and 60) intravenous injections
of Pd-NPs at 0–12 µg/kg dose. Serum
cytokine concentrations were assessed at
the 90th day post-exposure
Effects on the immune system
The highest dose of Pd-NPs (12 µg/kg) induced a significant
reduction of IL-1α, IL-4, IL-6, IL-10, IL-12, and GM-CSF
compared to controls.
The 1.2 µg/kg dose induced also a significant reduction of
IL-1α. Interleukin-10 was significantly reduced at all the
investigated concentrations.
Iavicoli et al. [53]
Female Wistar rats
(n. 5 per group)
Animals were exposed to a single
intravenous injection of Pd-NPs at 0–12
µg/kg dose. Urinary protein
concentrations were analyzed at the 14th
day post exposure
Effects on the renal system
RBP: significantly increased in the 12 µg/kg group
(0.23 ± 0.07 mg/mL) compared to controls
(0.11 ± 0.03 mg/mL).
Beta2-microglobulin: significantly increased in the 12 µg/kg
group (0.97 ± 0.23 mg/mL) compared to controls
(0.40 ± 0.07 mg/mL).
Fontana et al. [54]
Female Wistar rats
(n. 4 per group)
Animals were exposed to a single
intravenous injection of Pd-NPs at 0–12
µg/kg dose. E2, FSH, LH, P and T levels
were determined in the serum samples
collected 14 days after exposure
Effects on the endocrine system
Dose 12 µg/kg: a significant reduction of E2 (0.012 ± 0.002
ng/mL) and T (0.47 ± 0.04 ng/mL) concentrations and an
increase of LH levels (23.09 ± 1.07 ng/mL) compared to
controls (E2: 0.032 ± 0.006; T: 0.80 ± 0.76; LH:
16.48 ± 1.31 ng/mL).
Dose 1.2 µg/kg: significant reduction for E2 (0.012 ± 0.005
ng/mL) and increase for LH (20.11 ± 1.14 ng/mL) compared
to controls.
Leso et al. [55]
Caco-2 cells, human colon adenocarcinoma cells; E2, estradiol; FSH, follicle-stimulating hormone; GM-CSF, granulocyte-macrophage colony stimulating factor; HaCat cells, human
keratinocyte cells; IL, interleukin; INF-γ, interferon-γ; LH, luteinizing hormone; MBC, minimum bactericidal concentration; MDR, multidrug resistant; MIC, minimum inhibitory
concentration; NPs, nanoparticles; P, progesterone; RBP, retinol binding protein; T, testosterone.
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5.1. Bacteria and Microbial Communities
To understand the interactions between nanomaterials and micro-organisms can be helpful to
define NP toxicological profiles on simple biological entities and extrapolate information to be verified
on more advanced organisms within more complex environmental conditions of exposure. In this
regard, an anti-microbial effect of Pd-NPs was reported by Adams et al. [51] toward Gram negative
Escherichia coli and Gram-positive Staphylococcus aureus bacterial cultures, although with a greater
inhibition in this latter strain, maybe in relation to the stronger resistance of the cell wall of negative
bacteria compared to positive ones. Interestingly, the anti-bacterial activity resulted dependent on the
NP size, and time-periods investigated. Antibacterial properties of Pd-NPs were also subsequently
confirmed on E. coli and S. aureus cultures [58] and on the novel multidrug resistant Cronobacter sakazakii
strain in which NPs were able to eradicate also biofilm bacterial growth, responsible for their multidrug
resistance [60]. A comparable antimicrobial impact was also evident with bimetallic-Pd-iron-NPs,
which demonstrated to significantly inhibit the growth rate of the dyphenyl ether degrading bacterial
strain Sphingomonas sp. PH-07 in a dose-dependent manner, at concentrations greater than 0.1 g/L [56].
In order to address whether the known antibacterial properties of the conducting polymer
polyaniline [61], could be enhanced via the incorporation with metal NPs, Pt-Pd colloidal solutions as
well as Pt-Pd-polyaniline nanocomposites were explored for their action against selective Gram positive
(Streptococcus sp. and Staphylococcus sp.) and Gram-negative bacteria (E. coli and Klebsiella sp.) [57].
Nanocomposite materials exhibited improved antibacterial activity compared to pristine polyaniline.
Interestingly, Pt-Pd individual nano-metal colloids did not exhibit any antibacterial activity, suggesting
that the enhanced biological impact could be dependent on the interaction between metal NPs and
a pristine polyaniline matrix as well as on the greater reactivity of smaller NPs in the nano-composites.
The possibility to employ Pd-NPs in the remediation of groundwater, wastewater and sediments,
raised concerns among possible effects these NPs may exert on environmental microbial communities
once released into the environment [59]. Therefore, the impact of Pd-NPs on the marine bacteria
was assessed on a single eco-toxicological model of marine bacterium, V. fischeri, as well as on
active bio-remediating microbial communities incubated under laboratory biogeochemical conditions
mimicking those occurring in situ. Pd-NPs showed nor toxic effects on V. fischeri, nor alterations
in the total bacterial community structure, as its biodiversity was increased compared to the not
exposed community. Additionally, concerning respiratory metabolisms, the negligible effect on
organohalide respiration activities, as well as the dose-dependent inhibition of sulfate reduction
and methanogenesis, further support the lack of ecotoxic effects of Pd-NPs on marine microbiome.
Comparably, no significant effects on the number of colony forming units or on the total soil
community metabolic fingerprint could be detected in soil microbial communities exposed to Pd-NPs
in experimental microcosm conditions of exposure serving as a direct analog of ecological system [26].
No differences could be also detected between the variable NP concentrations employed, maybe in
relation to the immobilization of NPs on soil organic compounds, such as humic acids.
Additionally, the antiplasmodial activity of Pd-NPs was demonstrated by Rajakumar et al. [33]
in mice intraperitoneally inoculated with Plasmodium berghei-infected red blood cells. The untreated
controls showed a progressively increasing parasitemia, while animals treated via the oral route with
Pd-NPs showed a 78.13% decrease in parasitemia with a reported inhibitory concentration 50 value of
16.44 mg/kg/body weight.
5.2. Animal Models
Concerning in vivo results, investigations conducted on female Wistar rats, proved the ability of
Pd-NPs to significantly affect the immune system of treated animals inducing alterations in the serum
levels of several cytokines secreted by different T helper (Th) lymphocyte subsets [52,53]. A subacute
(14 days) exposure to increasing doses of Pd-NPs was able to induce a general, although not significant,
upward trend, in all cytokine serum concentrations investigated, while a significant increase was
only determined by the highest dose of Pd-NPs (12 µg/kg) [52]. These findings may suggest that
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Pd-NPs could exert a significant and generalized stimulatory impact on the immune system of exposed
rats. However, when investigated in a sub-chronic time frame, such cytokine increasing trend was
not more evident [53]. Repeated injections of Pd-NPs, in fact, induced a decreasing trend in serum
levels in most of the cytokines investigated, with the highest concentration (12 µg/kg) determining
significant inhibitory effects compared to controls, supporting a more complex interaction between
these nanomaterials and the immune system, related also to the time points investigated.
As another possible target organ of the Pd-NP toxic action, the effects on the renal system was
recently assessed in Wistar rats acutely exposed via the intravenous route to a wide range of NP
concentrations. Results showed an increasing trend in urinary Pd levels demonstrating that Pd
urinary concentrations were directly associated with the administered doses. Additionally, urinary
concentration of low, retinol binding protein andβ2-microglobulin, and high molecular weight proteins
were employed to assess the nephrotoxic action of Pd-NPs [54]. Interestingly, the highest administered
dose (12 µg/kg) was able to induce a significant increase in urinary retinol binding protein and
β2-microglobulin levels compared to controls. This may suggest that Pd-NPs may exert a nephrotoxic
action at the renal tubular level. In fact, these low molecular weight proteins are excreted in urine
in small quantities when tubular function is normal, while an increase in their urinary excretion is
indicative of renal tubular damage. As a confirmation of this specific damage, ultra-structural analysis
of kidney specimens revealed subcellular dose-dependent morphological alterations with the main
target in the proximal and distal tubular epithelium. However, these preliminary results need to be
confirmed also to define possible Pd-NP molecular mechanisms of action.
More recently, a first attempt to investigate the endocrine disruptive potential of Pd-NPs
was performed by our group of research in an animal model of sexually mature female Wistar
rats sub-acutely exposed to NPs via a single tail vein injection [55]. An abnormal function of
the hypothalamic–pituitary–gonadal axis was detected as demonstrated by the reduced serum
concentrations of estradiol (E2) and testosterone (T) and the increased level of luteinizing hormone
(LH) in treated animals compared to controls, which become significant at the highest exposure
dose (12 µg/kg). Overall, these results demonstrated the ability of Pd-NPs to significantly affect the
normal sex hormone levels, thus suggesting that they may play an important role in disrupting the
physiological functions of the female reproductive system of Wistar rats.
6. Discussion
Over these last years, the enhancing interest in the synthesis and application of Pd-NPs,
together with their consequent increasing release into the community and occupational environments,
have raised concerns regarding possible adverse effects exerted on ecosystems and human health.
Particular attention has been focused on the health of workers who may be repeatedly and long-term
exposed to high doses of these nanomaterials, whose toxico-kinetic and dynamic behavior is still
not fully understood. In this emerging scenario, this is the first attempt to comprehensively analyze
the state of the art concerning Pd-NP toxicological behavior on simple and more complex biological
systems in order to extrapolate information useful to guide suitable risk assessment processes and
point out future research needs.
Although no definite conclusions can be drawn concerning the eco-toxicological impact of
Pd-NPs, the adverse effects reported on plant/seed models in vitro [27,28,39] do not allow to
exclude a potentially serious risk for plant reproductive success and growth, as well as for the
ecosystem functions.
Regarding Pd-NP antimicrobial properties, a significant inhibitory effect on bacterial growth
was evident in pure microbial cultures [51,60] while it was not evident in more complex soil
and marine microbial communities under experimental conditions mimicking those of the natural
environment [26,59]. This may be dependent on the possible interactions that NPs may have with
environmental compounds that may, in turn, prevent strong influences on microbial communities.
Overall, these data point out the importance of combining standard eco-toxicity tests, microbial
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metabolic assessments, and analyses of microbial community composition, in a multifaced approach
to evaluate the impact of NPs on the environmental microbiota and underlined molecular mechanisms
of action [59].
The majority of the reviewed in vitro studies reported significant cytotoxic [4,29–31,34,36] and
immuno-modulatory effects [29,37,38] induced by Pd-NP exposure on diverse animal and human cells.
Interestingly, different responses to NP treatment were determined in cell cultures used as models for
the upper and lower part of the respiratory tract, maybe in relation to the differences in particle uptake,
and culture media employed, which may change the NP bio-molecular corona, therefore affecting NP
toxicological profiles [29]. In this scenario, more complex tri-dimensional in vitro models, resembling
healthy and chronic bronchitis-like mucosa, may be useful to achieve data to be easily extrapolated to
an in vivo context and useful to define areas of the respiratory tract, as well as pathological conditions,
characterized by a greater susceptibility to the NP toxicity [42].
Interestingly, in vitro studies are generally useful to define possible NP molecular mechanisms of
action. However, current evidence on Pd-NPs do not allow to define specific conclusions in this regard,
as no uniform results were reported concerning the role of such chemicals as triggers of oxidative stress
reactions, apoptotic pathways, DNA damage cascades as well as cell cycle disturbances. Additionally,
it cannot be excluded that the type, i.e., organic ligands, surfactants, polymers and dendrimers,
and variable concentrations of chemical stabilizers employed in NP preparation, may influence their
toxicological profile. Therefore, further investigation seems necessary to define the role that the
complex interplay between the different NP physico-chemical properties, cellular growth media and
peculiar cellular-type features may have in determining different patterns of cytotoxicity.
In this regard, Pd-NP structural diversity and plasticity on supporting matrix [34,39] size, also in
a very narrow distribution [51], chemical composition as well as surface functionalization [32,35],
may all represent key NP properties potentially affecting their toxicological behavior. This may
finally suggest the possibility to modify nanomaterial bioactivity changing NP physico-chemical
characterization, therefore supporting the “safe by design” concept. This argues for nanomaterials
that, while maintaining most of their innovative and revolutionary physico-chemical properties, are at
the same time characterized by absent or lower toxicity. From an occupational health perspective, this
may lead to a safer production and application of such materials, possibly preventing the development
of adverse health effects.
Experiments carried out on animal models are extremely important to primarily define the
toxico-kinetic and dynamic- behavior of NPs, as well as to identify possible biological indicators of
exposure and early effect. Several organ systems have been reported to be affected by NP exposure,
from the immune to the endocrine, as well as the renal systems [52–55,62]. However, it remains to
be elucidated whether early alterations detected in sub-acute, sub-chronic conditions of exposure,
i.e., cytokine changes, alteration in hormonal serum concentrations, as well as increase in urinary
protein content, may persist in the long term, and their possible role in disease development and
manifestation. Future research, in this perspective, should be focused on the health impact of low-dose,
long term conditions of exposure, as those potentially experienced in real workplace settings.
Interestingly, concerning the immuno-modulatory effects of Pd-NPs on cytokine production
and/or release, preliminary investigation on this topic in vivo [52,53] failed to show a significant
preferential development of a specific cytokine secretion profile that may be responsible for an
imbalance toward a cellular or humoral immune response. This may reflect the complexity of the
Pd-NP interaction with biological systems in vivo which may be affected by modes of exposure,
penetration of physiological barriers, solubility in biological media as well as the bio-molecular corona
formation, which may all change the impact of the Pd-NP insult.
From an occupational health perspective, the possibility to extrapolate from animal investigations
possible biomarkers of exposure and effects seems absolutely important. Considering the still existing
practical difficulties in environmental monitoring of workplace NP exposure, due to the lack of
standardized procedures and dosimetric parameters to be measured, biological monitoring may
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provide complementary information concerning exposure occurring by all routes, considering the
inter-individual variabilities in the toxicokinetic of chemicals [63]. In this regard, the Pd elemental
content in biological matrices should be investigated and validated as a possible indicator of
internal dose in real occupational exposure settings. On the other side, alterations in nephrotoxic,
immunological and hormonal parameters should be verified and confirmed as possible biomarkers of
early effects in in field studies. The suitable definition of Pd-NP target organs, may be important to
understand possible conditions of susceptibility due to pre-existing alterations/pathologies in such
organs, which may deserve particular attention from an occupational health point of view [64].
7. Conclusions
This review represents the first attempt to achieve a more comprehensive knowledge of the
toxicological profile of Pd-NPs. Although the potential for these nanomaterials to affect the ecosystem
function, to exert cytotoxic and pro-inflammatory effects in vitro as well as to induce early alterations
in different target organs in in vivo models has been reported, further investigations appear absolutely
necessary to confirm such preliminary findings.
These should take advantage of a more comprehensive characterization of the physico-chemical
properties of Pd-NPs in order to get a deeper understanding of the complex interplay between their
intrinsic features and the detected health effects. Additionally, field studies strongly encourage defining
the environmental levels of exposure to Pd-NPs in real workplace settings. Environmental assessment
should be accompanied by biological monitoring investigations focused on verifying and validating
experimental biomarkers of exposure and early effects in a real exposure contexts. Overall, this seems
important to support the definition of adequate strategies for the evaluation of the risks derived
from Pd-NP exposure, and, in a precautionary manner, to guide the adoption/implementation of
comprehensive preventive and protective strategies to manage such emerging risks and protect the
health and safety of workers.
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Abbreviations
3D model Three dimensional model
A2780 Human ovarian cancer cells
A375 Human skin malignant melanoma cells
A549 Immortalized alveolar basal human epithelial cells
CA Cysteamine
Caco-2 Human colon adenocarcinoma cells
E2 Estradiol
FSH Follicle-stimulating hormone
GM-CSF Granulocyte-macrophage colony stimulating factor
Hacat Human keratinocyte cells
HeLa Human epithelial cervical cancer cells
HepG2 Human liver cancer cells G2
IL Interleukin
INF-γ Interferon-γ
LC50LH Lethal concentration 50Luteinizing hormone
LPS Lypopolysaccharide
MBC Mimum bactericidal concentration
MDR Multidrug resistant
MIC Minimum inhibitory concentration
MPA Mercaptopropionic acid
n.s. Not significant
MRC-5 Human fetal lung fibroblast cells
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NPs Nanoparticles
P Progesterone
Pd Palladium
PBECs Primary bronchial epithelial cells
PGE2 Prostaglandin E2
PHA Phytohemagglutinin-L
PBMCs Peripheral blood mononuclear cells
Pt Platinum
Rat-1 Rat embryo fibroblasts
RBPROS Retinol binding proteinReactive oxygen species
SD Standard deviation
T Testosterone
THP-1 Human monocyte leukaemia cells
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